Research site 645 — St. Petersburg, Florida

Research site 645 is a clinical research site located in St. Petersburg, Florida, United States 33713.

Crixeo Clinical Trials Trust Score: 4/100 (FAILING). This profile has not yet been claimed by the site owner.

Research site 645 has participated in 1 clinical trials.

Therapeutic areas: Relapsing Multiple Sclerosis.

Sponsors: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in St. Petersburg

Browse all research sites in Florida · View every site in St. Petersburg

Sponsor Feasibility Report

Trust Score: 4/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research site 645?

Research site 645 has a Crixeo Trust Score of 4/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research site 645 conducted?

Research site 645 has 1 clinical trials on record. Their work covers Relapsing Multiple Sclerosis.

Is Research site 645 accredited by Crixeo Clinical Trials?

Research site 645 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research site 645?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.